Jean Lang

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

Arunee Sabchareon, Derek Wallace, Chukiat Sirivichayakul et al. · The Lancet · 2012 · 814 citations

Veterinary Medicine, Child Health, Infectious Diseases +17

Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres

Y Mouton, S. Alfandari, M. Valette et al. · AIDS · 1997 · 363 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Safety and Efficacy of Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine Formulations in Nonhuman Primates

Farshad Guirakhoo, Z. Zhang, Gene Myers et al. · Journal of Virology · 2004 · 253 citations · Full text

Life Sciences, Biotechnology, Infectious Diseases +17

Treatment of Severe Colchicine Overdose with Colchicine-Specific Fab Fragments

Frédéric J. Baud, A. Sabouraud, Éric Vicaut et al. · New England Journal of Medicine · 1995 · 234 citations · Full text

Pharmacy, Pharmacology, Toxicology +10

Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax™-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All

Farshad Guirakhoo, Scott Kitchener, Dennis Morrison et al. · Human Vaccines · 2006 · 192 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17